3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function.
Biomedicine & Pharmacotherapy（2019）
Abstract
•AKBA inhibited Taxol-resistant cancer cell A2780/Taxol in vitro.•AKBA inhibited A2780/Taxol xenograft tumor growth in vivo.•AKBA reversed MDR proteins to exert its anti-cancer potency.
MoreTranslated text
Key words
3-acetyl-11-keto-beta-boswellic acid,Ovarian cancer,Multidrug resistance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined